Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call Prepared Remarks Transcript
Aurinia Pharmaceuticals Inc. held its Annual General Meeting on June 3, 2026. The meeting was chaired by CEO Kevin Tang, with Stephen Robertson serving as Corporate Secretary. Key discussions included the company's performance and future strategies.
- ▪The Annual General Meeting was properly called according to Aurinia's bylaws.
- ▪Kevin Tang acted as the Chair of the meeting.
- ▪Stephen Robertson served as the Corporate Secretary for the meeting.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4911562-aurinia-pharmaceuticals-inc-auph-shareholder-analyst-call-prepared-remarks-transcript"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
